TY  - JOUR
AU  - Agnelli, Giancarlo
AU  - Muñoz Martín, Andrés Jesús
AU  - Verso, Melina
PY  - 2020
DO  - 10.1056/NEJMoa1915103
SN  - 1533-4406
UR  - https://hdl.handle.net/20.500.14352/126239
T2  - New England Journal of Medicine
AB  - BACKGROUND Recent guidelines recommend consideration of the use of oral edoxaban or rivaroxaban for the treatment of venous thromboembolism in patients with cancer. However, the benefit of these oral agents is limited by the increased risk of bleeding...
LA  - eng
M2  - 1599
PB  - Massachusetts Medical Society
KW  - Cáncer
KW  - Trombosis
KW  - Apixabán
KW  - Anticoagulantes orales de accion directa
KW  - Enfermedad tromboembólica venosa
TI  - Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
TY  - journal article
VL  - 382
ER  -